These data suggest that interaction of TUBB4A/MYH9 is not only necessary for protection of the nucleus during migration of prostate cancer cells, but also for inducing activation of GSK3β/β-catenin signaling and subsequently influencing tumor growth and metastasis. Here, GSK3B is linked to prostate carcinoma.